Alpha Tau Medical Ltd.
DRTS
$4.06
$0.184.64%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | -2.53% | -7.16% | -8.44% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 1.01% | 5.90% | 13.03% | |
| Operating Income | -- | -1.01% | -5.90% | -13.03% | |
| Income Before Tax | -- | -8.93% | -17.67% | -21.08% | |
| Income Tax Expenses | -- | -62.50% | 9.09% | -145.76% | |
| Earnings from Continuing Operations | -- | -8.89% | -17.67% | -20.65% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -8.89% | -17.67% | -20.65% | |
| EBIT | -- | -1.01% | -5.90% | -13.03% | |
| EBITDA | -- | -0.82% | -5.79% | -13.22% | |
| EPS Basic | -- | -7.99% | -16.83% | -19.89% | |
| Normalized Basic EPS | -- | -4.23% | -21.32% | -21.32% | |
| EPS Diluted | -- | -7.99% | -16.83% | -19.89% | |
| Normalized Diluted EPS | -- | -4.23% | -21.32% | -21.32% | |
| Average Basic Shares Outstanding | -- | 0.79% | 0.73% | 0.75% | |
| Average Diluted Shares Outstanding | -- | 0.79% | 0.73% | 0.75% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |